glp-1 drug market size Receptor Agonist Size, Share GLP-1 Market Size, Share |

DPP-4i, dipeptidyl peptidase-4 inhibitor

Sure enough, exendin-4 displayed all the same effects as GLP-1, triggering insulin secretion from the pancreas and slowing digestion

doi:10.1186/s12933-021-01366-8 2026 The Author(s)

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice

doi: 10.1523/JNEUROSCI.6326-11.2012 34 MerchenthalerILaneMShughrueP

Deficiency of L-cells development and GLP-1 secretion in T2DM GLP-1 has two active forms, GLP-1amide and GLP-1 released in a biphasic manner: the first phase is rapidly released within 1530 min after nutrient intake, followed by the second phase at 90120 min